Tekfen, Bunge and Continental Grain have reinvested in the nitrogen fertiliser substitute producer through a series D round repotedly valuing it at almost $2bn.

US-based crop nutrition technology developer Pivot Bio completed a $430m series D round yesterday that included industrial conglomerate Tekfen and agribusinesses Bunge and Continental Grain.

Singaporean state-owned investment firm Temasek and venture capital firm DCVC co-led the round with backing from Generation Investment Management, Rockefeller Capital Management, Breakthrough Energy Ventures (BEV), Prelude Ventures, Pavilion Capital and private investor Roger Underwood.

Tekfen and Bunge were represented in the round by their respective corporate venturing units, Tekfen Ventures and Bunge Ventures. It…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?